| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.29 | 3e-05 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.14 | 4e-05 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.14 | 4e-05 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.18 | 5e-05 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.14 | 6e-05 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.18 | 6e-05 |